FDA Finds Undeclared Pharmaceuticals in OxyElite and Seven Slim
According to The Plain Dealer, the U.S. Food and Drug Administration (FDA) is warning consumers that two weight loss supplements, OxyElite Pro and Seven Slim, contain pharmaceutical ingredients that were hidden from consumers.
Flouxetine Found in OxyElite
Lot No. 216732 of OxyElite Pro Super Thermogenic is sold as a purple pill in a white bottle, and it contains the anti-depressant fluoxetine. Flouxetine is a selective serotonin reuptake inhibitor, or SSRI, commonly sold under the trade names Prozac and Sarafem.
This drug treats depression, bulimia, obsessive-compulsive disorder (OCD), panic disorder, and premenstrual dysphonic disorder (PMDD). They can also cause serious side effects like suicidal thoughts, seizures, and can interact with medications, which can cause heart rhythm disturbances or death.
There have been many cases of liver damage in connection with previous formulations of OxyElite Pro, including a Cleveland woman in 2013. USPlabs recalled the pills because 50 similar cases of liver illness occurred nationwide, and it led to more than 20 hospitalizations, two liver transplants, and one death. This resulted in the company discontinuing the production of OxyElite Pro in October of 2013 with the last stock expiring in October 2016
Carcinogen Detected in Seven Slim
Seven Slim contains phenolphthalein, which was banned by the FDA in the 1990's because it was potentially carcinogenic. It was an active ingredient in popular laxatives such as Ex-Lax and was reclassified by the FDA in 1997 as “not generally recognized as safe” after some animal tests showed an increased risk of cancer after exposure to the chemical.
The FDA recommends that consumers should stop using these and if you have experienced side effects from these medications then contact a doctor immediately.